INTS

INTENSITY THERAPEUTICS INC

INTS·45828J103·US·Common Stock·Healthcare - Biotechnology-13D/G

INTS (INTENSITY THERAPEUTICS INC) is held by 8 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($108,933), GEODE CAPITAL MANAGEMENT, LLC ($93,426), VANGUARD FIDUCIARY TRUST CO ($37,396). Net institutional sentiment: Mixed.

8
Holders
$245,540
Total Value
40% (5)
Consensus
2 buying - 3 selling
13F: Insider & Congress: Updated regularly
INTS

Smart Money Verdict

View all
Loading verdict
Held by 8 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Jul 1, 2026 · Activists Aug 14, 2025 · Congress none

InsiderTJTalamo JosephVest 1K shJun 30, 2026
InsiderWMWesolowski John MVest 4K shJun 30, 2026
InsiderBHBENDER LEWIS HVest 38K shMar 26, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
26,569(+57.8%)$108,9330.0%-30.57%
21
Decreased
22,787(-12.4%)$93,4260.0%-86.33%
0
Unchanged
9,121$37,3960.0%-38.27%
0
Unchanged
1,148$4,7070.0%-64.59%
0
Unchanged
200$8200.0%-38.27%
0
New
42$1720.0%-11.46%
17
Unchanged
20$820.0%-97.04%
0
Decreased
1(-99.5%)$40.0%-56.37%
0
Exited
0(-100.0%)$1,1760.0%-30.27%
0
INTSINTSINTENSITY THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used